Pre-Seed vs Seed vs Series A in 2026: Round Size, Valuation, and Dilution

Median round sizes in 2026 run from roughly $500K at pre-seed to $3.2M at seed to $12M at Series A — and Series A's median pre-money valuation just hit an all-time high of $49.3 million, according to Carta's State of Private Markets data.

Pre-Seed vs Seed vs Series A: The 2026 Numbers Side by Side

The three stages differ on nearly every dimension that matters to a founder deciding when to raise and how much to ask for. The table below lines up round size, valuation, dilution, instrument, and what investors expect at each stage, using Carta's most recent private-market data.

Sources: Carta State of Pre-Seed Q1 2026, Carta State of Private Markets, and Zeni's Series A valuation analysis, checked September 24, 2026.

Pre-Seed: Funding the Idea-to-Prototype Phase

Pre-seed is the earliest institutional or quasi-institutional round, funding the move from concept to something tangible — a prototype, a waitlist, early usage data. Investors are betting almost entirely on the team and the market opportunity, not on traction, because there usually isn't much traction to point to yet.

Carta's State of Pre-Seed Q1 2026 report puts the median valuation cap at $10M for SAFE rounds under $1M, rising to $15M for rounds between $1M and $2.5M. Typical dilution on a $1M-$2.4M SAFE runs 19-20%, though a meaningful share of deals exceed 25% — a wider range than seed or Series A, reflecting how much more variable pre-seed terms are deal to deal.

Seed: Proving the Model Works

Seed funds the search for product-market fit: a product in market, early users or paying customers, and a hypothesis about repeatable growth. The 2026 median seed round is roughly $3.2M at a median post-money valuation near $24.3M (about $16M pre-money), per Carta's tracking — but that median masks a wide AI/non-AI split. AI-native startups raise seed rounds at valuations roughly 42% above the overall median, while typical non-AI B2B SaaS companies price closer to $14M-$16M pre-money.

Dilution at seed has been unusually stable: Carta's data shows a median right around 20% for seven straight quarters, regardless of whether valuations were rising or flat over that period — a sign that the split between capital raised and equity given up has become more standardized even as headline valuation numbers move.

Series A: Proving How Big This Can Get

Series A is where the question changes from "does this work?" to "how big can this get, and how fast?" Institutional VCs write $5M-$15M+ checks, expect $1M-$3M+ ARR with 2-3x year-over-year growth, and a lead investor typically takes a board seat and negotiates the term sheet for the rest of the round.

Series A's median pre-money valuation reached an all-time high of $49.3 million in 2026, up from $48 million in Q1 2025 — roughly a 9% year-over-year increase, according to Carta's private-markets data. AI companies again command a premium: median AI Series A pre-money valuation runs around $84 million, nearly double the all-sector median, reflecting how much investor demand has concentrated into AI-native businesses at this stage.

Where the tradeoffs actually are

Pre-seed wins on speed and flexibility — a SAFE can close in weeks with minimal legal cost — but loses on price certainty: valuation caps are negotiated with the least data available, and founders often don't know their true dilution until a priced round forces conversion. Series A wins on capital and validation — a $49.3M median pre-money is real buying power and a real signal to the market — but loses on speed and control: diligence is deeper, the process takes months, and a board seat changes governance permanently.

Seed sits in between and is arguably the highest-variance stage: the same "seed" label now covers $1M rounds on minimal traction and $5M "seed extension" rounds with real revenue, which is part of why Carta's median masks such a wide AI-premium split. A founder comparing their term sheet to a "seed round" benchmark should check which flavor of seed the benchmark is actually describing.

Which Stage Should You Actually Raise?

If you have a team and a credible idea but no product yet, target pre-seed: angels, micro-VCs, and accelerators, not multi-stage VCs. If you have a live product with early users or $5K-$50K MRR and a hypothesis about what drives growth, target seed — and expect AI-native positioning to move your valuation range meaningfully if it's genuine, not cosmetic. If you have $1M+ ARR, 2-3x year-over-year growth, and unit economics that hold up under diligence, you're a credible Series A candidate; below that bar, most institutional Series A investors will pass regardless of how strong the narrative is.

The consistent thread across Carta's data, as of September 2026, is that dilution has stayed close to 20% at both seed and Series A even as valuations climbed — meaning the rising numbers reflect more capital changing hands per point of equity, not founders giving up more of their company to raise the same amount. That's a founder-favorable trend worth watching for whether it holds through 2027.